Mannisol A

Mannitol, the active ingredient in Mannisol A, is an osmotic diuretic presented as an injection solution for intravenous use. It reduces intracranial pressure, promotes diuresis in acute renal failure, and facilitates drug delivery in clinical settings.

GNH USA supplies Mannisol A as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Mannisol A is an osmotic diuretic used in conditions where fluid shifts are therapeutic.

- Reduction of intracranial pressure: helps lower elevated pressure in patients with traumatic brain injury or neurosurgical emergencies. - Promotion of diuresis in acute renal failure: increases urine output to assist renal clearance. - Facilitation of drug delivery: serves as an osmotic agent to improve the distribution of certain intravenous medications such as contrast media.

Mannitol may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Headache: mild to moderate discomfort. - Nausea or vomiting: gastrointestinal upset. - Thirst or dry mouth: sensation of increased fluid loss. - Electrolyte imbalance: especially hyponatremia or hypokalemia. - Dizziness or light‑headedness.

Serious or Rare Side Effects: - Pulmonary edema: fluid accumulation in the lungs. - Severe dehydration: excessive fluid loss leading to hypotension. - Anaphylactic reaction: rare but potentially life‑threatening allergy. - Worsening renal failure: in patients with compromised kidney function. - Cardiac arrhythmia: due to electrolyte disturbances.

Mannisol A requires careful monitoring and specific safety measures.

- Monitor fluid balance: assess input, output, and electrolyte status regularly. - Adjust dose in renal impairment: reduce volume in patients with decreased kidney function. - Avoid rapid infusion: administer over the recommended time to prevent hemodynamic shifts. - Caution in cardiac disease: watch for signs of volume overload or heart failure. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Mannisol A can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Loop diuretics: additive diuretic effect may cause severe electrolyte loss. - Insulin: fluid shifts can potentiate hypoglycemia. - ACE inhibitors: increased risk of hypotension.

Moderate Interactions (Monitor Closely): - NSAIDs: may diminish diuretic response. - Antihypertensives: can enhance blood‑pressure lowering effects. - Contrast media: combined osmotic load may increase renal stress.